SCHEMBL6512168

SCHEMBL6512168

COc1ccc(Sc2cc(Nc3cccc(F)c3)nc(NC(CC(C)C)C(=O)O)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.40
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
SLC2A1 P11166 1/20 0.37
KEAP1 Q14145 1/20 0.37
KDR P35968 1/20 0.37
GALR2 O43603 2/20 0.36
TP53 P04637 1/20 0.36
GALR1 P47211 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6512174 1.00 CTSK (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6512117 0.93 CTSK (0.38) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6512111 0.93 CTSK (0.38) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6507808 0.93 CTSK (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513831 0.91 CTSK (0.44) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6506223 0.89 CTSK (0.42) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6510135 0.88 CTSK (0.44) CTSK
SCHEMBL6510161 0.88 CTSK (0.44) CTSKL3MBTL1SMN1; SMN2LMNATP53
SCHEMBL8299305 0.87 CTSK (0.38) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6528931 0.86 KCNH3 (0.41) CTSKALDH1A1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed